Info

Exiqon A/S is a Denmark-based company active in the pharmaceutical industry. It is a provider of gene expression analysis products for the life sciences. The Company’s product portfolio includes the miRCURY LNA product line for microRNA research. It has also developed its proprietary Locked Nucleic Acids (LNA) and Anthraquinone (AQ) technologies. Exiqon has entered into partnerships with Roche Diagnostics, Invitrogen, Fischer Scientific International Inc. and Luminex Corporation. The Company has distributors in Australia, China, Hong Kong, India, Italy, Japan, South Korea, New Zealand, Singapore and Spain. Exiqon A/S is operational through Exiqon, Inc in the United States. On February 29, 2008, the Company acquired Oncotech that develops and markets diagnostic tests designed to optimize the treatment selection for cancer patients.